Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

DBVT

DBV Technologies (DBVT)

DBV Technologies SA
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:DBVT
日付受信時刻ニュースソース見出しコード企業名
2024/06/0605 : 30GlobeNewswire Inc.DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:DBVTDBV Technologies SA
2024/06/0505 : 30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2024NASDAQ:DBVTDBV Technologies SA
2024/06/0105 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
2024/05/3122 : 51GlobeNewswire Inc.DBV Technologies Announces Plan to Implement ADS Ratio ChangeNASDAQ:DBVTDBV Technologies SA
2024/05/3105 : 30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming EAACI 2024 CongressNASDAQ:DBVTDBV Technologies SA
2024/05/3005 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DBVTDBV Technologies SA
2024/05/1805 : 38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
2024/05/1805 : 30GlobeNewswire Inc.DBV Technologies Announces Plan to Implement ADS Ratio ChangeNASDAQ:DBVTDBV Technologies SA
2024/05/1705 : 30GlobeNewswire Inc.DBV Technologies Announces Results of its 2024 Combined General MeetingNASDAQ:DBVTDBV Technologies SA
2024/05/1705 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
2024/05/1005 : 30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming Investor ConferencesNASDAQ:DBVTDBV Technologies SA
2024/05/0805 : 30GlobeNewswire Inc.DBV Technologies Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:DBVTDBV Technologies SA
2024/04/2605 : 30GlobeNewswire Inc.Combined General Meeting of May 16, 2024NASDAQ:DBVTDBV Technologies SA
2024/04/0505 : 43GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024NASDAQ:DBVTDBV Technologies SA
2024/03/0823 : 33GlobeNewswire Inc.DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration DocumentNASDAQ:DBVTDBV Technologies SA
2024/03/0806 : 30GlobeNewswire Inc.DBV Technologies Reports Full Year 2023 Financial Results and Business UpdateNASDAQ:DBVTDBV Technologies SA
2024/03/0506 : 30GlobeNewswire Inc.DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024NASDAQ:DBVTDBV Technologies SA
2024/02/2106 : 30GlobeNewswire Inc.DBV Technologies to Participate in Upcoming AAAAI 2024 CongressNASDAQ:DBVTDBV Technologies SA
2024/02/1506 : 06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DBVTDBV Technologies SA
2024/01/1706 : 30GlobeNewswire Inc.Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHFNASDAQ:DBVTDBV Technologies SA
2023/12/2220 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DBVTDBV Technologies SA
2023/12/0506 : 30GlobeNewswire Inc.Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  NASDAQ:DBVTDBV Technologies SA
2023/11/1006 : 30GlobeNewswire Inc.DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in ToddlersNASDAQ:DBVTDBV Technologies SA
2023/11/0706 : 30GlobeNewswire Inc.Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023NASDAQ:DBVTDBV Technologies SA
2023/11/0305 : 30GlobeNewswire Inc.DBV Technologies to Present New Data at ACAAI 2023NASDAQ:DBVTDBV Technologies SA
2023/11/0221 : 00Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:DBVTDBV Technologies SA
2023/11/0107 : 48Dow Jones NewsDBV Tech Gets Requested Feedback from FDA on Comfort Safety StudiesNASDAQ:DBVTDBV Technologies SA
2023/11/0105 : 30GlobeNewswire Inc.DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial ResultsNASDAQ:DBVTDBV Technologies SA
2023/10/2805 : 30GlobeNewswire Inc.DBV Technologies to Report Third Quarter 2023 Financial Results and Business UpdateNASDAQ:DBVTDBV Technologies SA
2023/10/1615 : 00GlobeNewswire Inc.DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial OfficerNASDAQ:DBVTDBV Technologies SA
 Showing the most relevant articles for your search:NASDAQ:DBVT